Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis - Otu, A A; Bongomin, F; Bazaz, R; Harris, C; Denning, D W; Kosmidis, C (Mycoses, 2019)